Author

Edmund O. Walden

Observed names: E. O. Walden, E. Walden, Edmund O Walden

Institutions: University of Florida Health, University of Florida, UF Health Cancer Center

Observed institutions: University of Florida Health, University of Florida, North Florida/South Georgia Veterans Health System, UF Health Cancer Center

OpenAlex ID: A5035296195

Adequacy of Published Oncology Randomized Controlled Trials to Provide Therapeutic Details Needed for Clinical Application

2010 · Jennifer M. Duff, Helen Leather, et al. · JNCI Journal of the National Cancer Institute · 103

Managing cetuximab hypersensitivity-infusion reactions: incidence, risk factors, prevention, and retreatment.

2010 · Thomas J George, Kourtney D Laplant, et al. · PubMed · 44

Adequacy of published oncology randomized controlled trials to provide details needed for clinical application

2009 · J. M. Duff, H. L. Leather, et al. · Journal of Clinical Oncology · 1

Retrospective review of stage III non-small cell lung cancer (NSCLC) patients treated with carboplatin/paclitaxel plus radiotherapy followed by docetaxel

2007 · M. R. Patel, M. Weidner, et al. · Journal of Clinical Oncology

Works count: 4

Citation count: 148

H-index: 2

I10-index: 2